Course Website Locator: epi286-01

Harvard School of Public Health

The following course websites match your request:

Spring 2 2010

Dr. S. Schneeweiss
2.5 credits
Seminars, lectures. Two 2-hour sessions each week.

Using current examples and with the participation of active researchers in pharmacoepidemiology, this course addresses a range of study designs and analytic techniques for observational studies on the utilization, safety, and effectiveness of pharmaceuticals. Students will develop an understanding of how to plan, implement, analyze, and criticize pharmacoepidemiologic studies. Original research will be presented by principal investigators, followed by intensive discussions on design options, analytic strategies, and sensitivity analyses of confounding and misclassification bias. Lectures will provide methodological background and will cover applied issues typically encountered in pharmacoepidemiology. This course is intended primarily for graduate students considering a career in the pharmaceutical/biotech industry, pharmaceutical benefits management, or in national regulatory bodies.
Course activities: Class discussion, reading homework, individual class presentations.
Course notes: EPI 203, EPI 204, EPI 221, and BIO 210 or BIO 223, or signature of instructor required; familiarity with logistic regression and survival analysis is expected.

Course evaluations are an important method for feedback on the quality of course offerings. The submission of a course evaluation is a requirement for this course. Your grade for the course will be made available only after you have submitted responses to at least the first three questions of the on-line evaluation for this course.

Spring 2 2009

Dr. S. Schneeweiss
2.5 credits
Seminars, lectures. Two 2-hour sessions each week.

Using current examples and with the participation of active researchers in pharmacoepidemiology, this course addresses a range of study designs and analytic techniques for observational studies on the utilization, safety, and effectiveness of pharmaceuticals. Students will develop an understanding of how to plan, implement, analyze, and criticize pharmacoepidemiologic studies. Original research will be presented by principal investigators, followed by intensive discussions on design options, analytic strategies, and sensitivity analyses of confounding and misclassification bias. Lectures will provide methodological background and will cover applied issues typically encountered in pharmacoepidemiology. This course is intended primarily for graduate students considering a career in the pharmaceutical/biotech industry, pharmaceutical benefits management, or in national regulatory bodies.
Course activities: Class discussion, reading homework, individual class presentations.
Course notes: EPI 203, EPI 204, EPI 221, and BIO 210 or BIO 223, or signature of instructor required; familiarity with logistic regression and survival analysis is expected.

Course evaluations are an important method for feedback on the quality of course offerings. The submission of a course evaluation is a requirement for this course. Your grade for the course will be made available only after you have submitted responses to at least the first three questions of the on-line evaluation for this course.

Spring 2 2008

Dr. S. Schneeweiss
2.5 credits
Course not offered 2006-2007; offered alternate years.
Seminars, lectures. Two 2-hour sessions each week.

Using current examples and with the participation of active researchers in pharmacoepidemiology, this course addresses a range of study designs and analytic techniques for observational studies on the utilization, safety, and effectiveness of pharmaceuticals. Students will develop an understanding of how to plan, implement, analyze, and criticize pharmacoepidemiologic studies. Original research will be presented by principal investigators, followed by intensive discussions on design options, analytic strategies, and sensitivity analyses of confounding and misclassification bias. Lectures will provide methodological background and will cover applied issues typically encountered in pharmacoepidemiology. This course is intended primarily for graduate students considering a career in the pharmaceutical/biotech industry, pharmaceutical benefits management, or in national regulatory bodies.
Course activities: Class discussion, reading homework, individual class presentations.
Course notes: EPI 203, EPI 204, EPI 221, and BIO 210 or BIO 223, or signature of instructor required; familiarity with logistic regression and survival analysis is expected.

Course evaluations are an important method for feedback on the quality of course offerings. The submission of a course evaluation is a requirement for this course. Your grade for the course will be made available only after you have submitted responses to at least the first three questions of the on-line evaluation for this course.

Copyright © 2012 The President and Fellows of Harvard College